Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-8364 in Advanced Solid Tumors
NCT07446153Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-8364 in solid tumor, sponsored by Hengrui. Started Mar 2026; status: recruiting.
02
Drugs
HRS-8364
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07446153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07446153.